{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,19]],"date-time":"2026-11-19T10:43:34Z","timestamp":1795085014317,"version":"4.10.2"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,10,26]],"date-time":"2019-10-26T00:00:00Z","timestamp":1572048000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,10,26]],"date-time":"2019-10-26T00:00:00Z","timestamp":1572048000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"The Natural Science Foundation of Zhejiang Province","award":["LY15H160063"],"award-info":[{"award-number":["LY15H160063"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"published-print":{"date-parts":[[2019,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n              <jats:sec>\n                <jats:title>Background and objectives<\/jats:title>\n                <jats:p>The survival rate of patients with advanced oesophageal cancer is very low and can vary significantly, even among patients with the same TNM stage. It is important to look for indicators that are economical and readily available to predict overall survival. The aim of this study was to determine whether lymphocyte-to-monocyte ratio (LMR) and neutrophil-to-lymphocyte ratio (NLR) could be potential predictors of survival in patients with advanced oesophageal squamous cell carcinoma (ESCC) undergoing concurrent chemoradiotherapy.<\/jats:p>\n              <\/jats:sec>\n              <jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Differences in survival among 204 patients with advanced oesophageal cancer who underwent concurrent chemoradiotherapy were collected and analysed. Univariate and multivariate COX regression analyses were used to investigate the association between blood inflammatory markers and patient survival before treatment.<\/jats:p>\n              <\/jats:sec>\n              <jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Univariate COX regression analyses showed that a history of alcohol use, neutrophil count, LMR, NLR, tumour length, and N stage were significantly associated with the survival of tumour patients receiving concurrent chemoradiotherapy. Multivariate COX regression analysis showed that NLR and LMR were predictors of outcome in tumour patients receiving chemoradiotherapy. According to receiver operating characteristic (ROC) curve analysis, the AUC of LMR and NLR was 0.734 and 0.749, and the best cutoff point for LMR and NLR was 3.03 and 2.64, respectively.<\/jats:p>\n              <\/jats:sec>\n              <jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>LMR and NLR can be used to predict the survival of patients with advanced oesophageal cancer receiving concurrent chemoradiotherapy, thereby providing clinicians with suggestions for further treatment options.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12885-019-6157-4","type":"journal-article","created":{"date-parts":[[2019,10,26]],"date-time":"2019-10-26T14:04:36Z","timestamp":1572098676000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":59,"title":["Predictive value of lymphocyte-to-monocyte ratio (LMR) and neutrophil-to-lymphocyte ratio (NLR) in patients with oesophageal cancer undergoing concurrent chemoradiotherapy"],"prefix":"10.1186","volume":"19","author":[{"given":"Ke-Jie","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Fang","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-Hao","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chang-Lin","family":"Zou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,10,26]]},"reference":[{"issue":"1","key":"6157_CR1","doi-asserted-by":"publisher","first-page":"5","DOI":"10.3322\/caac.21254","volume":"65","author":"RL Siegel","year":"2015","unstructured":"Siegel RL, Miller KD, Jemal A. Cancer statistics, 2015. CA Cancer J Clin. 2015;65(1):5\u201329.","journal-title":"CA Cancer J Clin"},{"issue":"3","key":"6157_CR2","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1136\/gutjnl-2014-308124","volume":"64","author":"A M","year":"2015","unstructured":"M A, et al. Global incidence of oesophageal cancer by histological subtype in 2012. Gut. 2015;64(3):381\u20137.","journal-title":"Gut"},{"issue":"2","key":"6157_CR3","doi-asserted-by":"publisher","first-page":"115","DOI":"10.3322\/caac.21338","volume":"66","author":"C W","year":"2016","unstructured":"W C, et al. Cancer statistics in China, 2015. CA Cancer J Clin. 2016;66(2):115\u201332.","journal-title":"CA Cancer J Clin"},{"issue":"3","key":"6157_CR4","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1016\/j.suronc.2017.06.002","volume":"26","author":"K F","year":"2017","unstructured":"F K, S E, M N. Current trends in multimodality treatment of esophageal and gastroesophageal junction cancer - review article. Surg Oncol. 2017;26(3):290\u20135.","journal-title":"Surg Oncol"},{"key":"6157_CR5","doi-asserted-by":"crossref","unstructured":"V, V., M. AC, and L. SH, Advances in radiotherapy Management of Esophageal Cancer. J Clin Med, 2016. 5(10): p. undefined.","DOI":"10.3390\/jcm5100091"},{"issue":"12","key":"6157_CR6","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1007\/s12032-018-1211-7","volume":"35","author":"S Martini","year":"2018","unstructured":"Martini S, et al. Volumetric modulated arc therapy (VMAT) in the treatment of esophageal cancer patients. Med Oncol. 2018;35(12):150.","journal-title":"Med Oncol"},{"key":"6157_CR7","doi-asserted-by":"crossref","unstructured":"Yang GQ, et al. Intensity-modulated radiotherapy at high-volume centers improves survival in patients with esophageal adenocarcinoma receiving trimodality therapy. Dis Esophagus. 2019;32(8).","DOI":"10.1093\/dote\/doy124"},{"issue":"2","key":"6157_CR8","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1016\/j.ijrobp.2011.12.041","volume":"84","author":"G Nicolini","year":"2012","unstructured":"Nicolini G, et al. Volumetric modulation arc radiotherapy with flattening filter-free beams compared with static gantry IMRT and 3D conformal radiotherapy for advanced esophageal cancer: a feasibility study. Int J Radiat Oncol Biol Phys. 2012;84(2):553\u201360.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"3","key":"6157_CR9","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1016\/j.ijrobp.2017.07.025","volume":"99","author":"S Warren","year":"2017","unstructured":"Warren S, et al. Potential of proton therapy to reduce acute hematologic toxicity in concurrent Chemoradiation therapy for esophageal Cancer. Int J Radiat Oncol Biol Phys. 2017;99(3):729\u201337.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"3","key":"6157_CR10","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1016\/j.ijrobp.2017.06.2450","volume":"99","author":"M Xi","year":"2017","unstructured":"Xi M, et al. Comparative outcomes after definitive Chemoradiotherapy using proton beam therapy versus intensity modulated radiation therapy for esophageal Cancer: a retrospective, single-institutional analysis. Int J Radiat Oncol Biol Phys. 2017;99(3):667\u201376.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"6157_CR11","doi-asserted-by":"publisher","DOI":"10.1038\/srep30057","volume":"6","author":"YK Chen","year":"2016","unstructured":"Chen YK, et al. Plasma matrix metalloproteinase 1 improves the detection and survival prediction of esophageal squamous cell carcinoma. Sci Rep. 2016;6:30057.","journal-title":"Sci Rep"},{"issue":"3","key":"6157_CR12","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1038\/tpj.2016.9","volume":"17","author":"M Gusella","year":"2017","unstructured":"Gusella M, et al. Genetic prediction of long-term survival after neoadjuvant chemoradiation in locally advanced esophageal cancer. Pharmacogenomics J. 2017;17(3):252\u20137.","journal-title":"Pharmacogenomics J"},{"issue":"3","key":"6157_CR13","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1002\/jso.23651","volume":"110","author":"D Yuan","year":"2014","unstructured":"Yuan D, et al. The preoperative neutrophil-lymphocyte ratio predicts recurrence and survival among patients undergoing R0 resections of adenocarcinomas of the esophagogastric junction. J Surg Oncol. 2014;110(3):333\u201340.","journal-title":"J Surg Oncol"},{"issue":"1","key":"6157_CR14","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1007\/s00268-017-4144-y","volume":"42","author":"N Hirahara","year":"2018","unstructured":"Hirahara N, et al. A novel prognostic scoring system using inflammatory response biomarkers for esophageal squamous cell carcinoma. World J Surg. 2018;42(1):172\u201384.","journal-title":"World J Surg"},{"issue":"6","key":"6157_CR15","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1007\/s12032-017-0976-4","volume":"34","author":"AM Conway","year":"2017","unstructured":"Conway AM, et al. Significance of blood neutrophil-to-lymphocyte ratio for prognostic stratification of patients with gastroesophageal junction adenocarcinoma in the era of the 8th edition of the American joint committee on Cancer (AJCC8) staging. Med Oncol. 2017;34(6):116.","journal-title":"Med Oncol"},{"issue":"7","key":"6157_CR16","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1111\/his.13835","volume":"74","author":"MS Toss","year":"2019","unstructured":"Toss MS, et al. The prognostic significance of lysosomal protective protein (cathepsin a) in breast ductal carcinoma in situ. Histopathology. 2019;74(7):1025\u201335.","journal-title":"Histopathology"},{"issue":"5","key":"6157_CR17","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1016\/j.jhep.2019.01.007","volume":"70","author":"X QG","year":"2019","unstructured":"QG X, et al. A novel HBx genotype serves as a preoperative predictor and fails to activate the JAK1\/STATs pathway in hepatocellular carcinoma. J Hepatol. 2019;70(5):904\u201317.","journal-title":"J Hepatol"},{"issue":"3","key":"6157_CR18","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1111\/cas.13936","volume":"110","author":"S Mase","year":"2019","unstructured":"Mase S, et al. ZNF671 DNA methylation as a molecular predictor for the early recurrence of serous ovarian cancer. Cancer Sci. 2019;110(3):1105\u201316.","journal-title":"Cancer Sci"},{"issue":"3","key":"6157_CR19","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1097\/SLA.0000000000001743","volume":"265","author":"JC Chan","year":"2017","unstructured":"Chan JC, et al. The lymphocyte-to-monocyte ratio is a superior predictor of overall survival in comparison to established biomarkers of Resectable colorectal Cancer. Ann Surg. 2017;265(3):539\u201346.","journal-title":"Ann Surg"},{"key":"6157_CR20","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1186\/s12885-016-2089-4","volume":"16","author":"KA Charles","year":"2016","unstructured":"Charles KA, et al. Systemic inflammation is an independent predictive marker of clinical outcomes in mucosal squamous cell carcinoma of the head and neck in oropharyngeal and non-oropharyngeal patients. BMC Cancer. 2016;16:124.","journal-title":"BMC Cancer"},{"key":"6157_CR21","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.lungcan.2018.08.012","volume":"124","author":"K Sekine","year":"2018","unstructured":"Sekine K, et al. Change in the lymphocyte-to-monocyte ratio is an early surrogate marker of the efficacy of nivolumab monotherapy in advanced non-small-cell lung cancer. Lung Cancer. 2018;124:179\u201388.","journal-title":"Lung Cancer"},{"key":"6157_CR22","first-page":"854670","volume":"2015","author":"GP Chen","year":"2015","unstructured":"Chen GP, et al. A nomogram to predict prognostic value of red cell distribution width in patients with esophageal Cancer. Mediat Inflamm. 2015;2015:854670.","journal-title":"Mediat Inflamm"},{"issue":"11","key":"6157_CR23","doi-asserted-by":"publisher","first-page":"3288","DOI":"10.1245\/s10434-018-6651-y","volume":"25","author":"Y Ishibashi","year":"2018","unstructured":"Ishibashi Y, et al. Prognostic value of preoperative systemic Immunoinflammatory measures in patients with esophageal Cancer. Ann Surg Oncol. 2018;25(11):3288\u201399.","journal-title":"Ann Surg Oncol"},{"issue":"2","key":"6157_CR24","doi-asserted-by":"publisher","first-page":"1794","DOI":"10.1002\/jcp.27052","volume":"234","author":"H Zhang","year":"2019","unstructured":"Zhang H, et al. The predictive value of a preoperative systemic immune-inflammation index and prognostic nutritional index in patients with esophageal squamous cell carcinoma. J Cell Physiol. 2019;234(2):1794\u2013802.","journal-title":"J Cell Physiol"},{"issue":"1","key":"6157_CR25","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1245\/s10434-017-6241-4","volume":"25","author":"A Gaitanidis","year":"2018","unstructured":"Gaitanidis A, et al. Markers of systemic inflammatory response are prognostic factors in patients with pancreatic neuroendocrine tumors (PNETs): a prospective analysis. Ann Surg Oncol. 2018;25(1):122\u201330.","journal-title":"Ann Surg Oncol"},{"issue":"1","key":"6157_CR26","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1038\/nrc2782","volume":"10","author":"M Chechlinska","year":"2010","unstructured":"Chechlinska M, Kowalewska M, Nowak R. Systemic inflammation as a confounding factor in cancer biomarker discovery and validation. Nat Rev Cancer. 2010;10(1):2\u20133.","journal-title":"Nat Rev Cancer"},{"issue":"2","key":"6157_CR27","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1007\/s00281-012-0344-6","volume":"35","author":"S Brandau","year":"2012","unstructured":"Brandau S, Dumitru CA, Lang S. Protumor and antitumor functions of neutrophil granulocytes. Semin Immunopathol. 2012;35(2):163\u201376.","journal-title":"Semin Immunopathol"},{"key":"6157_CR28","doi-asserted-by":"publisher","DOI":"10.4161\/onci.28273","volume":"3","author":"J Bastid","year":"2014","unstructured":"Bastid J, et al. Lymphocyte-derived interleukin-17A adds another brick in the wall of inflammation-induced breast carcinogenesis. Oncoimmunology. 2014;3:e28273.","journal-title":"Oncoimmunology"},{"issue":"1","key":"6157_CR29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3233\/BD-140386","volume":"35","author":"T Nazir","year":"2015","unstructured":"Nazir T, et al. Lymphocytopenia; induced by vinorelbine, doxorubicin and cisplatin in human cancer patients. Breast Dis. 2015;35(1):1\u20134.","journal-title":"Breast Dis"},{"issue":"7","key":"6157_CR30","doi-asserted-by":"publisher","first-page":"616","DOI":"10.7150\/jca.11727","volume":"6","author":"WW Xiao","year":"2015","unstructured":"Xiao WW, et al. A low lymphocyte-to-monocyte ratio predicts unfavorable prognosis in pathological T3N0 rectal Cancer patients following Total Mesorectal excision. J Cancer. 2015;6(7):616\u201322.","journal-title":"J Cancer"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-019-6157-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12885-019-6157-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-019-6157-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,24]],"date-time":"2020-10-24T23:09:27Z","timestamp":1603580967000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-019-6157-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10,26]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["6157"],"URL":"https:\/\/doi.org\/10.1186\/s12885-019-6157-4","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,10,26]]},"assertion":[{"value":"2 May 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 September 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 October 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All the procedures followed were in accordance with the ethical guidelines of the Helsinki Declaration. The study protocol was approved by the Medical Ethical Committee of the First Affiliated Hospital of Wenzhou Medical University. Because all the patients in this retrospective study had died, informed consent was obtained from their family members or their pretreatment authorized recipients.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1004"}}